Literature DB >> 8915481

pS2 expression induced by American ginseng in MCF-7 breast cancer cells.

R B Duda1, B Taback, B Kessel, D D Dooley, H Yang, J Marchiori, B M Slomovic, J G Alvarez.   

Abstract

BACKGROUND: Alternative medicines are frequently used by patients with breast cancer for general health benefits. American ginseng, an herbal remedy, purportedly alleviates treatment-induced postmenopausal symptoms.
METHODS: Estrogenic potential of American ginseng root extract to induce the expression of pS2, an estrogen-regulated gene, was evaluated in breast cancer cell lines MCF-7, T-47D, and BT-20 by Northern and Western blot analysis. Competitive studies were performed with ginseng in combination with tamoxifen. Cell proliferation assays were performed using the tetrazolium dye procedure and direct cell count.
RESULTS: Ginseng and estradiol induce the expression of pS2 RNA and protein in MCF-7 cells, whereas tamoxifen suppresses expression. Neither ginseng nor estradiol induced increased pS2 expression in T-47D or BT-20 cell lines. Although estradiol exhibited a proliferative effect and tamoxifen had an inhibitory effect, ginseng demonstrated no significant effect on cell proliferation.
CONCLUSIONS: The results of this study suggest that ginseng may exhibit estrogenlike effects on estrogen receptor-positive breast cancer cells by inducing pS2 expression and that the effect of ginseng may be mediated in part through the estrogen receptor. Because ginseng does not exhibit a proliferative effect, it may play a protective role against breast cancer rather than serve as a mitogen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915481     DOI: 10.1007/bf02306082

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  35 in total

1.  Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7.

Authors:  A M Nunez; S Jakowlev; J P Briand; M Gaire; A Krust; M C Rio; P Chambon
Journal:  Endocrinology       Date:  1987-11       Impact factor: 4.736

2.  Antitumoral activity of Panax ginseng extracts.

Authors:  K D Lee; R P Huemer
Journal:  Jpn J Pharmacol       Date:  1971-06

3.  Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

Authors:  K B Horwitz; W L McGuire
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

4.  Ginseng face cream and unexplained vaginal bleeding.

Authors:  M P Hopkins; L Androff; A S Benninghoff
Journal:  Am J Obstet Gynecol       Date:  1988-11       Impact factor: 8.661

5.  Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet.

Authors:  H Adlercreutz; H Honjo; A Higashi; T Fotsis; E Hämäläinen; T Hasegawa; H Okada
Journal:  Am J Clin Nutr       Date:  1991-12       Impact factor: 7.045

6.  Separation of acidic and neutral lipids by aminopropyl-bonded silica gel column chromatography.

Authors:  J G Alvarez; J C Touchstone
Journal:  J Chromatogr       Date:  1992-05-20

7.  Steroid receptor analyses of nine human breast cancer cell lines.

Authors:  K B Horwitz; D T Zava; A K Thilagar; E M Jensen; W L McGuire
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

8.  pS2 expression and response to hormonal therapy in patients with advanced breast cancer.

Authors:  L H Schwartz; F C Koerner; S M Edgerton; J M Sawicka; M C Rio; J P Bellocq; P Chambon; A D Thor
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

9.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

10.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

Authors:  F Denizot; R Lang
Journal:  J Immunol Methods       Date:  1986-05-22       Impact factor: 2.303

View more
  5 in total

Review 1.  A general description for Chinese medicine in treating premature ovarian failure.

Authors:  Jing Lin; Xue-Lian Li; Hui Song; Qian Li; Ming-Yan Wang; Xue-Min Qiu; Da-Jin Li; Ling Wang
Journal:  Chin J Integr Med       Date:  2017-03-07       Impact factor: 1.978

2.  Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.

Authors:  Wen-Fang Chen; Wai-Sum Lau; Pik-Yuen Cheung; De-An Guo; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.

Authors:  Debra L Barton; Heshan Liu; Shaker R Dakhil; Breanna Linquist; Jeff A Sloan; Craig R Nichols; Travis W McGinn; Philip J Stella; Grant R Seeger; Amit Sood; Charles L Loprinzi
Journal:  J Natl Cancer Inst       Date:  2013-07-13       Impact factor: 13.506

4.  American ginseng regulates gene expression to protect against premature ovarian failure in rats.

Authors:  Lei Zhu; Ji Li; Nannan Xing; Dongwei Han; Haixue Kuang; Pengling Ge
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 5.  The Safety and Efficacy of Botanicals with Nootropic Effects.

Authors:  Amy L Roe; Arvind Venkataraman
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.